1. Home
  2. APLM vs ZEO Comparison

APLM vs ZEO Comparison

Compare APLM & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • ZEO
  • Stock Information
  • Founded
  • APLM 2016
  • ZEO 2005
  • Country
  • APLM United States
  • ZEO United States
  • Employees
  • APLM N/A
  • ZEO N/A
  • Industry
  • APLM Blank Checks
  • ZEO
  • Sector
  • APLM Finance
  • ZEO
  • Exchange
  • APLM Nasdaq
  • ZEO NYSE
  • Market Cap
  • APLM 6.9M
  • ZEO 55.5M
  • IPO Year
  • APLM N/A
  • ZEO N/A
  • Fundamental
  • Price
  • APLM $5.33
  • ZEO $2.49
  • Analyst Decision
  • APLM
  • ZEO
  • Analyst Count
  • APLM 0
  • ZEO 0
  • Target Price
  • APLM N/A
  • ZEO N/A
  • AVG Volume (30 Days)
  • APLM 27.3K
  • ZEO 90.1K
  • Earning Date
  • APLM 08-13-2025
  • ZEO 08-18-2025
  • Dividend Yield
  • APLM N/A
  • ZEO N/A
  • EPS Growth
  • APLM N/A
  • ZEO N/A
  • EPS
  • APLM N/A
  • ZEO N/A
  • Revenue
  • APLM $198,000.00
  • ZEO $61,885,622.00
  • Revenue This Year
  • APLM $415.15
  • ZEO N/A
  • Revenue Next Year
  • APLM N/A
  • ZEO N/A
  • P/E Ratio
  • APLM N/A
  • ZEO N/A
  • Revenue Growth
  • APLM N/A
  • ZEO N/A
  • 52 Week Low
  • APLM $4.47
  • ZEO $1.05
  • 52 Week High
  • APLM $35.98
  • ZEO $4.75
  • Technical
  • Relative Strength Index (RSI)
  • APLM 44.49
  • ZEO 43.01
  • Support Level
  • APLM $5.33
  • ZEO $2.66
  • Resistance Level
  • APLM $6.56
  • ZEO $2.80
  • Average True Range (ATR)
  • APLM 0.54
  • ZEO 0.28
  • MACD
  • APLM -0.05
  • ZEO -0.09
  • Stochastic Oscillator
  • APLM 33.11
  • ZEO 1.65

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Share on Social Networks: